Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients - Stock, Sophia; Übelhart, Rudolf; Schubert, Maria-Luisa; Fan, Fuli; He, Bailin; Hoffmann, Jean-Marc; Wang, Lei; Wang, Sanmei; Gong, Wenjie; Neuber, Brigitte; Hückelhoven-Krauss, Angela; Gern, Ulrike; et al. (International journal of cancer, 2019)
Gesehen am 26.07.2019